Faster infection testing for ICU patients with sepsis
Part of Infections clinical trials.
This trial tests a new rapid test that can quickly identify the cause of a severe infection (sepsis) in ICU patients. The goal is to see if faster results help doctors choose the right treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been in the ICU for less than 24 hours
- You have sepsis or septic shock, but the exact germ causing it is not yet known
- You are expected to stay in the ICU for at least 2 days and can be followed for 28 days
- You or your legal representative can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This study compares different laboratory methods to find the exact germs causing your sepsis more quickly and accurately. Faster identification could mean better targeted treatment, potentially improving your recovery.
This study tests whether a faster lab method can correctly identify the germ causing an infection and check which antibiotics may work, using samples taken in the emergency department. It may help doctors choose the right treatment sooner for people with serious suspected infection.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.